Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Eli Lilly Leads Three Stocks Near Buy Points
12:56pm, Friday, 14'th Nov 2025
Eli Lilly stock hit an all-time high in Friday's stock market.
Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?
10:02am, Friday, 14'th Nov 2025
Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.
Health Rounds: Lilly blood thinner tops AstraZeneca's for heart procedure patients with diabetes
07:06am, Friday, 14'th Nov 2025
Blood-thinning drugs that doctors often prescribe interchangeably after procedures to reopen narrowed heart arteries don't work equally well in patients with diabetes, a study from India found.
It Looks Like Eli Lilly Will Become The Next Trillion Dollar Baby
02:22am, Friday, 14'th Nov 2025
Eli Lilly is poised to become the first $1 trillion pharmaceutical company, driven by explosive growth in its weight-loss drug, Mounjaro. LLY's earnings and sales growth have been exceptional, with qu
Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs
02:04pm, Thursday, 13'th Nov 2025
Novo Nordisk and Eli Lilly do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc , spokespeople for both companies said, rejecting a press release issued by the company
Can Equities Stabilize after the Government Reopens?
01:51pm, Thursday, 13'th Nov 2025
As traders position for year-end, the government shutdown is over, major market indices are filling gaps, and seasonal momentum looms.
Jefferies Group's Strategic Move: Vanguard Information Technology ETF Takes Center Stage
11:03am, Thursday, 13'th Nov 2025
Jefferies Group (Trades, Portfolio)'s Latest 13F Filing Reveals Strategic Portfolio Adjustments Jefferies Group (Trades, Portfolio) recently submitted its 13F
Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs
07:15am, Thursday, 13'th Nov 2025
Telehealth company Mangoceuticals said on Thursday it has partnered with Eli Lilly and Novo Nordisk to sell the drugmakers' blockbuster weight-loss drugs through its platform.
1 Incredible Reason to Buy LLY's Stock in November
04:25am, Thursday, 13'th Nov 2025
Eli Lilly is the market-share leader for weight-loss drugs. Coverage by government insurance programs is a huge win for the company.
Bitget Lists LLY, MA, UNH Stock Index Perpetual Futures as Cumulative Trading Volume on Bitget hits $3 Billion
01:17am, Thursday, 13'th Nov 2025
VICTORIA, Seychelles, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), has announced the official addition of LLYUSDT, MAUSDT, UNHUSDT stock index perpetual futu
MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential
03:30pm, Wednesday, 12'th Nov 2025
MeiraGTx Holdings plc secures a transformative partnership with Eli Lilly, granting worldwide rights to its AAV-AIPL1 gene therapy for LCA4. MGTX receives $75 million upfront, up to $400 million in mi
Eli Lilly Stock: This Trade On The Rising Stock Holds $1,415 In Profit Potential
11:42am, Wednesday, 12'th Nov 2025
Eli Lilly's strong price action and high ratings present a bull call spread trading opportunity with large profit potential and clearly defined risk parameters.
Is Eli Lilly Stock's Run Too Hot? Here Is How It Can Crash
10:20am, Wednesday, 12'th Nov 2025
Eli Lilly stock (NYSE: LLY) has surged by 21% this month, driven by strong third-quarter earnings and a favorable obesity drug pricing deal with the U.S. government. However, this recent success doesn
IBM's Quantum Push Intensifies, LLY Price Target Hike, ONON Soars 20% on Earnings
10:01am, Wednesday, 12'th Nov 2025
ON Holding (ONON) jumped higher with an earnings beat and guidance raise giving shares a platform to rally. Diane King Hall points to sales doubling in the Asia-Pacific region as a big catalyst.
Cramer's Mad Dash: Eli Lilly
09:54am, Wednesday, 12'th Nov 2025
Jim Cramer breaks down why he's keeping an eye on shares of Eli Lilly.
